Search results for: Competition
Filter search results
Price Competition and Biosimilars
23 June 2010
Virtually all models forecast that price competition will be less intense and price declines modest in comparison to the generics model. Many models, however, miss or underestimate factors and trends…
Competition in the NHS: ‘Payment by Results’
17 August 2010
Jon Sussex, Deputy Director of the OHE, researches incentives and competition in UK health services. In July, he presented findings on ‘Payment by Results’ to the Health and Social Care…
OHE Lunchtime Seminar: Incentives for R&D, Competition and Intertemporal Effects of Payment Rules for Cures
13 May 2019
OHE Lunchtime Seminar with Pedro Pita Barros on ‘Incentives for R&D, Competition and Intertemporal Effects of Payment Rules for Cures’. To be held on 6 June 2019 from 12 p.m….
How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England
1 September 2009
…on the effectiveness of competition. Four key differences are identified: corporation tax, value added tax, pension costs and cost of capital. Critical barriers to implementing the competition policy are reviewed….
Innovative Competition in Medicine
1 January 1992
…need for shelters against the ‘perennial gale’ of innovative competition in relation to pharmaceuticals. Hence when I was encouraged to look again at industrial economic theory relevant to pharmaceutical pricing…
Biosimilar Competition: Lessons from Europe and Prospects for the US
14 March 2014, 12:00am
At this OHE Lunchtime Seminar, Professor Henry Grabowski presented the results of his recent research on competition in five European countries on Eprex® (epoetin alpha) and Neupogen® (filigrastim) and their…
OHE Lunchtime Seminar: Incentives for R&D, Competition and Intertemporal Effects of Payment Rules for Cures
5 June 2019, 11:00pm
…competing products appear; and, a third period when generic competition emerges. Demand in each period depends on how many patients were treated in previous periods. Similarly, payment/pricing rules used will…
Biosimilar Competition: Lessons from Europe and Prospects for the US
2 December 2014
…to encourage biosimilars, and physicians will become more experienced with them. Download Grabowski, H., 2014. Biosimilars Competition: Lessons from Europe and Prospects for the US. London: Office of Health…
Biosimilars: How Much Entry and Price Competition Will Result?
1 December 2010
This publication reports on a seminar intended to encourage further thought about the distinguishing characteristics of the market for biosimilars and the implications of these for potential savings. Economists and…